P. Marini

发表

Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL

C. Belka, K. Schulze-Osthoff, M. Bamberg, 2001, Oncogene.

Radiation-induced apoptosis in human lymphocytes and lymphoma cells critically relies on the up-regulation of CD95/Fas/APO-1 ligand.

C. Belka, F. Lang, K. Schulze-Osthoff, 1998, Radiation research.

Influence of hypoxia on TRAIL-induced apoptosis in tumor cells.

C. Belka, M. Weinmann, W. Budach, 2004, International journal of radiation oncology, biology, physics.

Combination of the pro-apoptotic TRAIL-receptor antibody mapatumumab with ionizing radiation strongly increases long-term tumor control under ambient and hypoxic conditions.

C. Belka, M. Niyazi, W. Budach, 2009, International journal of radiation oncology, biology, physics.

Combined treatment with lexatumumab and irradiation leads to strongly increased long term tumour control under normoxic and hypoxic conditions

C. Belka, M. Niyazi, W. Budach, 2009, Radiation oncology.

Combined treatment of colorectal tumours with agonistic TRAIL receptor antibodies HGS-ETR1 and HGS-ETR2 and radiotherapy: enhanced effects in vitro and dose-dependent growth delay in vivo

C. Belka, S. Welz, S. Denzinger, 2006, Oncogene.

Differential role of caspase-8 and BID activation during radiation- and CD95-induced apoptosis

C. Belka, K. Schulze-Osthoff, A. Stępczyńska, 2000, Oncogene.

Irradiation specifically sensitises solid tumour cell lines to TRAIL mediated apoptosis

C. Belka, P. Daniel, W. Budach, 2005, BMC Cancer.

Molecular requirements for the combined effects of TRAIL and ionising radiation.

C. Belka, W. Budach, V. Jendrossek, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiation sensitivity and apoptosis in human lymphoma cells

C. Belka, M. Bamberg, W. Budach, 2001, International journal of radiation biology.

Ionizing radiation and the activation of caspase-8 in highly apoptosis-sensitive lymphoma cells.

C. Belka, K. Schulze-Osthoff, M. Bamberg, 1999, International journal of radiation biology.

Glioma tropism of lentivirally transduced hematopoietic progenitor cells.

M. Weller, R. Möhle, W. Wick, 2010, International journal of oncology.

Efficacy of triple therapies including ionising radiation, agonistic TRAIL antibodies and cisplatin.

C. Belka, M. Niyazi, P. Daniel, 2009, Oncology reports.

Efficacy of a Triple Treatment with Irradiation, Agonistic TRAIL Receptor Antibodies and EGFR Blockade

C. Belka, M. Niyazi, P. Daniel, 2009, Strahlentherapie und Onkologie.

[Death inducing ligands in combination with ionizing radiation: objective and current knowledge].

C. Belka, M. Bamberg, W. Budach, 2003, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

The Journal of And Experimental Therapeutics

C. Belka, S. Welz, R. Meisch, 2001 .

Aurora kinase inhibitor ZM447439 induces apoptosis via mitochondrial pathways.

C. Belka, K. Lauber, A. Friedl, 2010, Biochemical pharmacology.

The tyrosine kinase Lck is required for CD95-independent caspase-8 activation and apoptosis in response to ionizing radiation

C. Belka, F. Lang, K. Schulze-Osthoff, 1999, Oncogene.

Apoptotic Cells Induce Migration of Phagocytes via Caspase-3-Mediated Release of a Lipid Attraction Signal

S. Baksh, C. Belka, K. Schulze-Osthoff, 2003, Cell.

Death receptor ligands: new strategies for combined treatment with ionizing radiation.

C. Belka, P. Marini, 2003, Current medicinal chemistry. Anti-cancer agents.

Drug evaluation: lexatumumab, an intravenous human agonistic mAb targeting TRAIL receptor 2.

P. Marini, 2006, Current opinion in molecular therapeutics.